homeostasis/metabolism
• on the NOD background, by 35 weeks of age and later, no mutants show hyperglycemia while 40% of NOD-sufficient mice develop diabetes by 35 weeks of age
|
immune system
• a 10-fold reduction in levels of peripheral CD4+ T cells is observed compared to controls
|
• CD8+ T cells are slightly over-represented in mutants (25%) compared to controls (16%)
|
• MHC class II molecule expression is almost completely absent from spleen cells
|
• mice do not develop diabetes (2 consecutive blood glucose measures >16.5 nM) up to 30 weeks of age
|
• female mutants show pancreatic infiltration by 15 weeks of age
|
• when recovered from NOD diabetic female recipients, islet grafts obtained from these class II-deficient NOD mice show severe infiltration and lack almost all insulin production
|
• at 15 weeks of age, around 2% of islets in female mutants show perinsulitis or insulitis compared with 75% in pre-diabetic and diabetic mice
|
hematopoietic system
• a 10-fold reduction in levels of peripheral CD4+ T cells is observed compared to controls
|
• CD8+ T cells are slightly over-represented in mutants (25%) compared to controls (16%)
|
endocrine/exocrine glands
• female mutants show pancreatic infiltration by 15 weeks of age
|
• when recovered from NOD diabetic female recipients, islet grafts obtained from these class II-deficient NOD mice show severe infiltration and lack almost all insulin production
|
• at 15 weeks of age, around 2% of islets in female mutants show perinsulitis or insulitis compared with 75% in pre-diabetic and diabetic mice
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
NOT | type 1 diabetes mellitus | DOID:9744 |
OMIM:222100 |
J:106081 |